DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

MOLBIO vs MOMSBELIEF: Stock Comparison

MOLBIO DIAGNOSTICS vs RAYS OF BELIEFUpdated 6 Nov 26, 4:08 PM ISTNSE & company filings

MOLBIO DIAGNOSTICS is the larger company by market capitalisation. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

MOLBIO leads 1; MOMSBELIEF leads 0 of 7

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

MOLBIOMOMSBELIEF

Valuation lens

What price are you paying?

Market CapContext only
₹15,523 Cr
₹512 Cr
EPSMOLBIO has the higher reading
₹5.1 ✓
₹1.33
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
MOLBIO is the larger company
₹15,523 Cr vs ₹512 Cr
EPS
MOLBIO has higher earnings per share
₹5.1 vs ₹1.33

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricMOLBIOMOMSBELIEF
Live Price₹1,339.3₹245.89
Day Change-4.57%-1.45%
Volume9.88 L52,494
52-Week High₹1,686.8₹314.95
52-Week Low₹926.35₹201.1
Distance from 52W High-20.6%-21.93%

Valuation

MetricMOLBIOMOMSBELIEF
Market Cap₹15,523 Cr₹512 Cr
EPS₹5.1₹1.33
Dividend Yield0%0%

Growth

MetricMOLBIOMOMSBELIEF
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricMOLBIOMOMSBELIEF
Net Margin0%0%

Shareholding

As of Sep 2026 • change vs previous quarter
MetricMOLBIOMOMSBELIEF
Promoter Holding41.29%0.22%
FII Holding1.59%▲ 0.08 pp2.4%▼ 5.94 pp
DII Holding19.08%▲ 2.71 pp10.42%▼ 0.82 pp
Public Holding38.03%▼ 2.79 pp18.41%▲ 6.76 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: MOLBIO DIAGNOSTICS and RAYS OF BELIEF.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.